Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Human Growth Hormone Drug Market Report 2016

  • QYR778188
  • 96 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Human Growth Hormone Drug

Revenue, means the sales value of Human Growth Hormone Drug

This report studies sales (consumption) of Human Growth Hormone Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Eli Lilly and Company (US)

Ferring Holding SA (Switzerland)

Genentech, Inc. (US)

GeneScience Pharmaceuticals Co., Ltd. (China)

Merck Serono SA (Switzerland)

Novo Nordisk A/S (Denmark)

Pfizer, Inc. (US)

Sandoz International GmbH (Germany)

Teva Pharmaceutical Industries Limited (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Human Growth Hormone Drug in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Human Growth Hormone Drug Market Report 2016

1 Human Growth Hormone Drug Overview

1.1 Product Overview and Scope of Human Growth Hormone Drug

1.2 Classification of Human Growth Hormone Drug

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Human Growth Hormone Drug

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Human Growth Hormone Drug (2011-2021)

1.4.1 United States Human Growth Hormone Drug Sales and Growth Rate (2011-2021)

1.4.2 United States Human Growth Hormone Drug Revenue and Growth Rate (2011-2021)

2 United States Human Growth Hormone Drug Competition by Manufacturers

2.1 United States Human Growth Hormone Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Human Growth Hormone Drug Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Human Growth Hormone Drug Average Price by Manufactures (2015 and 2016)

2.4 Human Growth Hormone Drug Market Competitive Situation and Trends

2.4.1 Human Growth Hormone Drug Market Concentration Rate

2.4.2 Human Growth Hormone Drug Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Human Growth Hormone Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Human Growth Hormone Drug Sales and Market Share by Type (2011-2016)

3.2 United States Human Growth Hormone Drug Revenue and Market Share by Type (2011-2016)

3.3 United States Human Growth Hormone Drug Price by Type (2011-2016)

3.4 United States Human Growth Hormone Drug Sales Growth Rate by Type (2011-2016)

4 United States Human Growth Hormone Drug Sales (Volume) by Application (2011-2016)

4.1 United States Human Growth Hormone Drug Sales and Market Share by Application (2011-2016)

4.2 United States Human Growth Hormone Drug Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Human Growth Hormone Drug Manufacturers Profiles/Analysis

5.1 Eli Lilly and Company (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Human Growth Hormone Drug Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Eli Lilly and Company (US) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Ferring Holding SA (Switzerland)

5.2.2 Human Growth Hormone Drug Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Genentech, Inc. (US)

5.3.2 Human Growth Hormone Drug Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Genentech, Inc. (US) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 GeneScience Pharmaceuticals Co., Ltd. (China)

5.4.2 Human Growth Hormone Drug Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Merck Serono SA (Switzerland)

5.5.2 Human Growth Hormone Drug Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Merck Serono SA (Switzerland) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Novo Nordisk A/S (Denmark)

5.6.2 Human Growth Hormone Drug Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Pfizer, Inc. (US)

5.7.2 Human Growth Hormone Drug Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Pfizer, Inc. (US) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Sandoz International GmbH (Germany)

5.8.2 Human Growth Hormone Drug Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Teva Pharmaceutical Industries Limited (Israel)

5.9.2 Human Growth Hormone Drug Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Teva Pharmaceutical Industries Limited (Israel) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

6 Human Growth Hormone Drug Manufacturing Cost Analysis

6.1 Human Growth Hormone Drug Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Human Growth Hormone Drug

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Human Growth Hormone Drug Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Human Growth Hormone Drug Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Human Growth Hormone Drug Market Forecast (2016-2021)

10.1 United States Human Growth Hormone Drug Sales, Revenue Forecast (2016-2021)

10.2 United States Human Growth Hormone Drug Sales Forecast by Type (2016-2021)

10.3 United States Human Growth Hormone Drug Sales Forecast by Application (2016-2021)

10.4 Human Growth Hormone Drug Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Human Growth Hormone Drug

Table Classification of Human Growth Hormone Drug

Figure United States Sales Market Share of Human Growth Hormone Drug by Type in 2015

Table Application of Human Growth Hormone Drug

Figure United States Sales Market Share of Human Growth Hormone Drug by Application in 2015

Figure United States Human Growth Hormone Drug Sales and Growth Rate (2011-2021)

Figure United States Human Growth Hormone Drug Revenue and Growth Rate (2011-2021)

Table United States Human Growth Hormone Drug Sales of Key Manufacturers (2015 and 2016)

Table United States Human Growth Hormone Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Human Growth Hormone Drug Sales Share by Manufacturers

Figure 2016 Human Growth Hormone Drug Sales Share by Manufacturers

Table United States Human Growth Hormone Drug Revenue by Manufacturers (2015 and 2016)

Table United States Human Growth Hormone Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Human Growth Hormone Drug Revenue Share by Manufacturers

Table 2016 United States Human Growth Hormone Drug Revenue Share by Manufacturers

Table United States Market Human Growth Hormone Drug Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Human Growth Hormone Drug Average Price of Key Manufacturers in 2015

Figure Human Growth Hormone Drug Market Share of Top 3 Manufacturers

Figure Human Growth Hormone Drug Market Share of Top 5 Manufacturers

Table United States Human Growth Hormone Drug Sales by Type (2011-2016)

Table United States Human Growth Hormone Drug Sales Share by Type (2011-2016)

Figure United States Human Growth Hormone Drug Sales Market Share by Type in 2015

Table United States Human Growth Hormone Drug Revenue and Market Share by Type (2011-2016)

Table United States Human Growth Hormone Drug Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Human Growth Hormone Drug by Type (2011-2016)

Table United States Human Growth Hormone Drug Price by Type (2011-2016)

Figure United States Human Growth Hormone Drug Sales Growth Rate by Type (2011-2016)

Table United States Human Growth Hormone Drug Sales by Application (2011-2016)

Table United States Human Growth Hormone Drug Sales Market Share by Application (2011-2016)

Figure United States Human Growth Hormone Drug Sales Market Share by Application in 2015

Table United States Human Growth Hormone Drug Sales Growth Rate by Application (2011-2016)

Figure United States Human Growth Hormone Drug Sales Growth Rate by Application (2011-2016)

Table Eli Lilly and Company (US) Basic Information List

Table Eli Lilly and Company (US) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Eli Lilly and Company (US) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table Ferring Holding SA (Switzerland) Basic Information List

Table Ferring Holding SA (Switzerland) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ferring Holding SA (Switzerland) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table Genentech, Inc. (US) Basic Information List

Table Genentech, Inc. (US) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech, Inc. (US) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information List

Table GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table Merck Serono SA (Switzerland) Basic Information List

Table Merck Serono SA (Switzerland) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Serono SA (Switzerland) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table Novo Nordisk A/S (Denmark) Basic Information List

Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table Pfizer, Inc. (US) Basic Information List

Table Pfizer, Inc. (US) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer, Inc. (US) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table Sandoz International GmbH (Germany) Basic Information List

Table Sandoz International GmbH (Germany) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sandoz International GmbH (Germany) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table Teva Pharmaceutical Industries Limited (Israel) Basic Information List

Table Teva Pharmaceutical Industries Limited (Israel) Human Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Pharmaceutical Industries Limited (Israel) Human Growth Hormone Drug Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Human Growth Hormone Drug

Figure Manufacturing Process Analysis of Human Growth Hormone Drug

Figure Human Growth Hormone Drug Industrial Chain Analysis

Table Raw Materials Sources of Human Growth Hormone Drug Major Manufacturers in 2015

Table Major Buyers of Human Growth Hormone Drug

Table Distributors/Traders List

Figure United States Human Growth Hormone Drug Production and Growth Rate Forecast (2016-2021)

Figure United States Human Growth Hormone Drug Revenue and Growth Rate Forecast (2016-2021)

Table United States Human Growth Hormone Drug Production Forecast by Type (2016-2021)

Table United States Human Growth Hormone Drug Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390